Biomarker testing for suspected autism spectrum disorder in early childhood: is such testing now feasible?
Wadsworth Center, Division of Translational Medicine, New York State Health Department, Empire State Plaza, Albany, NY 12201, USA. mizejew@wadsworth.org
Gerald J
GJ
Mizejewski
D015415:Biomarkers / Q000378:metabolism*; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000175:diagnosis* / Q000191:economics / Q000378:metabolism; D006801:Humans; D007223:Infant; D009414:Nerve Growth Factors / Q000378:metabolism; D009496:Neurotensin / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism
D015415:Biomarkers; D019208:Brain-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; C071951:neurotrophin 5; D012701:Serotonin; D014660:Vasoactive Intestinal Peptide; D009496:Neurotensin; D015740:Calcitonin Gene-Related Peptide; C073922:neurotrophin 4